Genmab Files IND for HuMax-TF-ADC PipelineReview.com (press release) COPENHAGEN, Denmark I July 18, 2013 I Genmab A/S (OMX: GEN) announced today the filing of an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start a Phase I dose escalation trial of HuMax-TF-ADC to ... |
